Nitrosamine Impurities Affecting Drug-Drug Interaction Studies – Learn More

Best Practices for Successful Phase 1 Studies: Minimizing Risk and Regulatory Pitfalls Clinical Discussion Program

Contact Us

You are invited to attend Celerion’s Clinical Discussion Program in San Diego, hosted by our own Stephanie Hagen, Senior Director of Business Development!

Hear from Phil Bach, Vice President of Global Clinical Research, on “Best Practices for Successful Phase 1 Studies: Minimizing Risk and Regulatory Pitfalls”. We anticipate an engaging and interactive discussion. Space is limited; don’t miss this opportunity to gain insights into executing your next Phase 1 study.

To RSVP (biopharmaceuticals only), please email Stephanie at stephanie.hagen@celerion.com by Friday, July 22.

 

DATE:

Wed, July 27, 2022

5:30 – 6:30pm Greetings, Reception, Hors d’oeuvres

6:30 – 7:30pm Presentation & Discussion

VENUE:

Arterra at the San Diego Marriott Del Mar

11966 El Camino Real, San Diego, CA 92130

Parking is included. Event format will be adjusted to accommodate COVID-19 precautions.